Photodynamic therapy for Barrett's esophagus: A review

Diseases of the Esophagus

Volumn 15, Issue 2, 2002, Pages 137-144

  Kelty, C J ^a   Marcus, S L ^b   Ackroyd, R ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b DUSA Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; HEMATOPORPHYRIN DERIVATIVE; OMEPRAZOLE; PHOTOFRIN; PHOTOSENSITIZING AGENT; PLACEBO; PROTOPORPHYRIN TIN; TETRAKIS(3 HYDROXYPHENYL)CHLORIN;

ADENOCARCINOMA; BALLOON; BARRETT ESOPHAGUS; CANCER INCIDENCE; CANCER REGRESSION; CLINICAL TRIAL; DIODE LASER; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG PENETRATION; DRUG RESPONSE; DYSPLASIA; ENDOSCOPIC THERAPY; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; ESOPHAGUS FISTULA; ESOPHAGUS INJURY; ESOPHAGUS MUCOSA; ESOPHAGUS STRICTURE; GASTROINTESTINAL TUMOR; HUMAN; LASER; LIVER DYSFUNCTION; MALIGNANT TRANSFORMATION; MAXIMUM TOLERATED DOSE; NAUSEA AND VOMITING; PHOTOACTIVATION; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY DISORDER; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SKIN CANCER; SKIN MANIFESTATION; SPECTRUM; STATISTICAL SIGNIFICANCE; SURVIVAL; TISSUE INTERACTION; TISSUE NECROSIS; TISSUE REGENERATION; WESTERN HEMISPHERE;

AMINOLEVULINIC ACID; ANTINEOPLASTIC AGENTS; BARRETT ESOPHAGUS; DIHEMATOPORPHYRIN ETHER; HEMATOPORPHYRIN PHOTORADIATION; HUMANS; LASERS; TREATMENT OUTCOME;

EID: 0036413399     PISSN: 11208694     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2050.2002.00243.x     Document Type: Review

References (40)

1. Haggitt R C. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994; 25: 982-993.
2. Barrett N. Chronic Peptic ulcer of the esophagus and esophagitis. Br J Surg 1950; 38: 175-182.
3. Devesa S S, Blot W J, Fraumeni J F Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049-2053.
4. Falk G W. Gastroesophageal reflux disease and Barrett's esophagus. Endoscopy 2001; 33: 109-118.
5. Cameron A J, Zinsmeister A R, Ballaerd D J, Carney J A. Prevalence of columnar lined Barrett's esophagus: comparison of population based clinical and autopsy findings. Gastroenterology 1990; 99: 918-922.
6. Burke A P, Sobin L H, Shekitka K M, Helwig E B. Dysplasia of the stomach and Barrett's esophagus: a follow up study. Mod Pathol 1991; 4: 336-341.
7. van Sandick J W, van Lanschot J J, Kuiken B W, Tytgat G N, Offerhaus G J, Obertop H. Impact of endoscopic biopsy surveillance of Barrett's esophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 1998; 43: 216-222.
8. Macdonald C E, Wicks A C, Playford R J. Final results from 10-year cohort of patients undergoing surveillance for Barrett's esophagus: observational study. BMJ 2000; 321: 1252-1255.
9. Gore S, Healey C J, Sutton R et al. Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy. Aliment Pharmacol Ther 1993; 7: 623-628.
10. Sampliner R E, Fenerty M B, Garewal H S. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. Gastrointest Endosc 1996; 44: 523-525.
11. Wang K K, Sampliner R E. Mucosal ablation therapy of Barrett's esophagus. Mayo Clin Proc 2001; 76: 433-437.
12. Ackroyd R, Kelty C J, Brown N J, Reed M W. The history of photodetection and photodynamic therapy. Photochem Photobiol 2001; 74: 656-669.
13. Dougherty T J, Gomer C J, Henderson B W et al. Photodynamic therapy. J Natl Cancer Inst 1998; 90: 889-905.
14. Tajiri H, Daikuzono N, Joffe S N, Oguro Y. Photoradiation therapy in early gastrointestinal cancer. Gastrointest Endosc 1987; 33: 88-90.
15. Dougherty T. Photodynamic therapy for early esophageal cancer. International Photodynamic therapy Association Meeting, April 1990: Buffalo, NY, USA.
16. Overholt B F, Panjehpour M, Haydek J M. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc 1999; 49: 1-7.
17. Ackryod R, Brown N J, Vernon D et al. 5-Aminolevulinic acid photosensitization of dysplastic Barrett's esophagus: a pharmacokinetic study. Photochem Photobiol 1999; 70: 656-662.
18. Gossner L, Stolte M, Sroka R et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology 1998; 114: 448-455.
19. Barr H, Tralau C J, Boulos P B, MacRobert A J, Tilly R, Bown S G. The contrasting mechanisms of colonic collagen damage between photodynamic therapy and thermal injury. Photochem Photobiol 1987; 46: 795-800.
20. Ackroyd R, Brown N J, Davis M F et al. Photodynamic therapy for dysplastic Barrett's esophagus: a prospective, double blind, randomised, placebo controlled trial. Gut 2000; 47: 612-617.
21. Kelty C J, Ackroyd R, Brown N J, Stephenson T J, Stoddard C J, Reed M W R. Photodynamic therapy for dysplastic Barrett's esophagus: long-term follow up. Br J Surg 2001; 88: 478.
22. Panjehpour M, Overholt B F, Haydek J M. Light sources and delivery devices for photodynamic therapy in the gastrointestinal tract. Gastrointest Endosc Clin North Am 2000; 10: 513-532.
23. Overholt B F, DeNovo R C, Panjehpour M, Peterson M G. A centering balloon for photodynamic therapy of esophageal cancer tested in a canine model. Gastrointest Endosc 1993; 39: 782-787.
24. Laukka M A, Wang K K. Initial results of using low dose photodynamic therapy in the treatment of Barrett's esophagus. Gastrointest Endosc 1995; 42: 59-63.
25. Wang K K, WongKeeSong L M, Nourbaksh A et al. Controlled trial of low dose photodynamic therapy for Barrett's esophagus. Gastroenterology 1997; 112: A676.
26. Wang K K, WongKeeSong L M, Nourbaksh A, Balm R. Can consistent tissue necrosis be achieved during photodynamic therapy for high grade dysplasia or cancer within Barrett's esophagus? Gastroenterology 1997; 112: A676.
27. Overholt B F, Haggitt R C, Bronner M P et al. A multicenter, partially blinded randomised study of the efficacy of photodynamic therapy (PDT) using porfimer sodium (POR) for the ablation of high grade dysplasia (HGD) in Barrett's esophagus (BE): Results of 6-month follow-up. Gastroenterology 2001; 120: A79.
28. Webber J, Kessel D, Fromm D. Side effects and photosensitization of human tissues after aminolevulinic acid. J Surg Res 1997; 68: 31-37.
29. Barr H, Shepherd N A, Dix A, Roberts D J, Tan W C, Krasner N. Eradication of high-grade dysplasia in columnar-lined (Barrett's) esophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet 1996; 348: 584-585.
30. Biddlestone L R, Barham C P, Wilkinson S P, Barr H, Shepherd N A. The histopathology of treated Barrett's esophagus: squamous reepithelialization after acid suppression and laser and photodynamic therapy. Am J Surg Pathol 1998; 22: 239-245.
31. Tan W C, Fulljames C, Stone N et al. Photodynamic therapy using 5-aminolevulinic acid for esophageal adenocarcinoma associated with Barrett's metaplasia. J Photochem Photobiol B. Biol 1999; 53: 75-80.
32. Jamieson N F, Mosse A, Bown S G, Lovat L B. Photodynamic therapy to eradicate dysplasia and early carcinoma in Barrett's esophagus. Gut 2002; 50: A6.
33. Ortner M, Zumbusch K, Liebetruth J et al. Photodynamic therapy of Barrett's esophagus after local administration of 5-aminolevulinic acid. Gastroenterology 1997; 112: A633.
34. Lovat L B, Whitelaw D E, Spencer G M et al. Photodynamic therapy for gastrointestinal tumours using mTHPC. Gastroenterology 1999; 116: A456.
35. Wang K K, WongKeeSong M, Nijhawan P, Nourbaksh A, Balm R. Does non-dysplastic Barrett's epithelium respond better to mucosal ablation? Gastroenterology 1998; 114: A700.
36. Van Laethem J L, Peny M O, Salmon I, Cremer M, Deviere J. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's esophagus. Gut 2000; 46: 574-577.
37. Byrne J P, Armstrong G R, Attwood S E. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation. Am J Gastroenterol 1998; 93: 1810-1815.
38. Krishnadath K K, Wang K K, Taniguchi K et al. Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy. Gastroenterology 2000; 119: 624-630.
39. Kelty C J, Ackryod R, Brown N J, Brown S B, Stephenson T J, Reed M W R. Photodynamic therapy (PDT) for Barrett's oesophagus- establishing the optimum dose of 5-aminolaevulinic acid (ALA). Gut 2002; 50: A123.
40. Curnow A, Haller J C, Bown S G. Oxygen monitoring during 5-aminolevulinic acid induced photodynamic therapy in normal rat colon. Comparison of continuous and fractionated light regimes. J Photochem Photobiol B: Biol 2000; 58: 149-155.